Anabolic steroids

Bailliere's Best Practice and Research in Clinical Endocrinology and Metabolism

Volumn 14, Issue 1, 2000, Pages 55-69

  Mottram, David R ^a   George, Alan J ^a  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Anabolic steroid addiction; Anabolic steroids; Dope testing; International Olympic Committee; Nandrolone; Performance enhancement; Testosterone

Indexed keywords

ANABOLIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLENBUTEROL; DIURETIC AGENT; MESTEROLONE; METANDIENONE; METENOLONE; METHYLTESTOSTERONE; NANDROLONE; NARCOTIC AGENT; PEPTIDE HORMONE; SALBUTAMOL; STANOZOLOL; TERBUTALINE; TESTOSTERONE;

AMENORRHEA; ATHEROSCLEROSIS; BEHAVIOR; BLOOD CLOTTING; BREAST TUMOR; DELAYED PUBERTY; DOPING; GYNECOMASTIA; HUMAN; HYPERTENSION; JAUNDICE; LABORATORY; LIVER CARCINOMA; MALE FERTILITY; MENSTRUATION DISORDER; MENTAL DISEASE; MUSCLE GROWTH; PROTEIN SYNTHESIS; REVIEW; SPORT; STATISTICS; TENDON DISEASE; TRAINING;

EID: 0033927275     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1053/beem.2000.0053     Document Type: Article

References (58)

1. George A J. The anabolic steroids and peptide hormones. Mottram D R. Drugs in Sport. 1996;173-218 E & FN Spon, London.
2. Wu F CW. Endocrine aspects of anabolic steroids. Clinical Chemistry. 43:1997;1289-1292.
3. Forbes G B. The effect of anabolic steroids on lean bodymass. The dose response curve. Metabolism. 34:1985;571-573.
4. Rockhold R W. Cardiovascular toxicity of anabolic steroids. Annual Review of Pharmacology and Toxicology. 33:1993;497-520.
5. Wilson J D. Androgen abuse by athletes. Endocrine Review. 9:1988;181-199.
6. Festle J. Explaining nandrolone. Athletics Weekly. 1999;16-17.
7. Greenblatt R B, Chaddha J S, Teran A Z. Aphrodisiacs. Iverson S D. Psychopharmacology: Recent Advances and Future Prospects. 1985;290-302 Oxford University Press, Oxford.
8. Lombardo J A, Hickson P C, Lamb D R. Anabolic/androgenic steroids and growth hormone. Lamb D R, Williams M H. Perspectives in Exercise Science and Sports Medicine. Ergogenics - Enhancement of Performance in Exercise and Sport. 4:1991;249-278 Brown and Benchmark, New York.
9. Goldman B. Death in the locker room. Steroids and Sport. 1984;Century Publishing, London.
10. Holma P K. Effects of an anabolic steroid (methandionone) on spermatogenesis. Contraception. 15:1979;151-162.
11. Laseler J T, Russell J A. Anabolic steroid-induced tendon pathology: a review of the literature. Medical Scientific Sports Executive. 23:1991;1-3.
12. Pope H G, Katz D L. Psychiatric and medical effects of anabolic-androgenic steroid use. Archives of General Psychiatry. 51:1994;375-382.
13. Kashkin K B, Kleber H D. Hooked on hormones? An anabolic steroid addiction hypothesis. Journal of the American Medical Association. 262:1989;3166-3170.
14. Yates W R, Perry P J, MacIndoe J. Psychosexual effects of 3 doses of testosterone cycling in normal men. Biological Psychiatry. 45:1999;254-260.
15. Choi P YL, Pope H G. Violence toward women and illicit androgenic anabolic steroid use. Annals of Clinical Psychiatry. 6:1994;22-25.
16. Perry H M, Wright D, Littlepage B NC. Dying to be big: a review of anabolic steroid use. British Journal of Sports Medicine. 26:1992;259-261.
17. Porcerelli J H, Sandler B A. Narcissism and empathy in steroid users. American Journal of Psychiatry. 152:1995;1627-1647.
18. Wade N. Anabolic steroids: doctors denounce them but athletes aren't listening. Science. 176:1972;1399-1403.
19. Todd T. Anabolic steroids: the gremlins of sport. Journal of Sports History. 14:1987;87-107.
20. Verroken M, Mottram D R. Doping control in sport. Mottram D R. Drugs in Sport. 1996;235-263 E & FN Spon, London.
21. Hatton C K, Catlin D H. Detection of androgenic anabolic steroids in urine. Clinics in Laboratory Medicine. 7:1987;655-668.
22. Catlin D H, Kammerer R C, Hatton C K. Analytical chemistry at the games of the XXIIIrd Olympiad in Los Angeles. Clinical Chemistry. 33:1987;319-327.
23. Catlin D H, Murray T H. Performance-enhancing drugs, fair competition, and Olympic sport. Journal of the American Medical Association. 276:1996;231-237.
24. Franke W W, Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clinical Chemistry. 43:1997;1262-1279.
25. Strauss R H, Yesalis C E. Anabolic steroids in the athlete. Annual Review of Medicine. 42:1991;449-457.
26. Tucker R. Abuse of anabolic-androgenic steroids by athletes and body builders: a review. Pharmaceutical Journal. 259:1997;171-179.
27. International Journal of Sports Psychology. 24:1993;74-78.
28. Haupt H A, Rovere G D. Anabolic steroids: a review of the literature. American Journal of Sports Medicine. 12:1984;469-484.
29. Elashoff J D, Jacknow A D, Shain S G, Braunstein G D. Effects of anabolic-androgenic steroids on muscular strength. Annals of Internal Medicine. 155:1991;387-393.
30. VanHelder W P, Kofman E, Tremblay M S. Anabolic steroids in sport. Canadian Journal of Sports Science. 16:1991;248-257.
31. Catlin D H, Hatton C K. Use and abuse of anabolic and other drugs for athletic enhancement. Advances in Internal Medicine. 36:1991;399-424.
32. Clarkson P M, Thompson H S. Drugs in sport. Research findings and limitations. Sports Medicine. 24:1997;366-384.
33. Freed D LJ, Banks A J, Longson D, Burley D M. Anabolic steroids in athletics: cross-over double-blind trial on weightlifters. British Medical Journal. 2:1975;471-473.
34. Bhasin S, Storer T W, Berman L. The effects of super-physiological doses of testosterone on muscle size and strength in normal men. New England Journal of Medicine. 335:1996;1-7.
35. Sylvester L J. Self-perceptions of the acute and long-range effects of anabolic-androgenic steroids. Journal of Strength and Conditioning Research. 9:1995;95-98.
36. Rogol A D, Yesalis C E. Anabolic-androgenic steroids and athletes: what are the issues? Journal of Endocrinological Metabolism. 74:1992;465-469.
37. Kleiner S M. Performance-enhancing aids in sport: health consequences and nutritional alternatives. Journal of the American College of Nutrition. 10:1991;163-176.
38. Matsumoto A M. Hormonal therapy of male hypogonadism. Endocrinological Metabolism Clinics of North America. 23:1994;857-875.
39. Littlepage B NC, Perry H M. Misusing anabolic drugs: possibilities for future policies. Addiction. 88:1993;1469-1471.
40. Yang Y T, McElliott M A. Multiple actions of β adrenergic agonists on skeletal muscle and adipose tissue. Biochemical Journal. 261:1989;1-10.
41. Haupt H A. Anabolic steroids and growth hormone. American Journal of Sports Medicine. 21:1993;468-474.
42. Delbeke F T. Doping in cyclism: results of unannounced controls in Flanders (1987-1994). International Journal of Sports Medicine. 17:1996;434-438.
43. Meilman P W, Crace R K, Presley C A, Lyerla R. Beyond performance enhancement: polypharmacy among collegiate users of steroids. Journal of the American College of Health. 44:1995;98-104.
44. Radakovich J, Broderick P, Pickell G. Rate of anabolic-androgenic steroid use among students in junior high school. Journal of the American Board of Family Practice. 6:1993;341-345.
45. Kindlundh A MS, Isacson D GL, Berglund L, Nyberg F. Factors associated with adolescent use of doping agents: anabolic-androgenic steroids. Addiction. 94:1999;543-553.
46. Durant R H, Middleman A B, Faulkner A H. Adolescent anabolic-androgenic steroid use, multiple drug use, and high school sports participation. Pediatric Exercise Science. 9:1997;150-158.
47. Pan D W, Baker J AW. Perceptual mapping of banned substances in athletics. Gender and sport-defined differences. Journal of Sport and Social Issues. 22:1998;170-182.
48. Middleman A B, DuRant R H. Anabolic steroid use and associated health risk behaviours. Sports Medicine. 21:1996;251-255.
49. Scarpino V, Arrigo A, Benzi G. Evaluation of prevalence of 'doping' among Italian athletes. Lancet. 336:1990;1048-1050.
50. Benzi G. Pharmacoepidemiology of the drugs used in sports as doping agents. Pharmacological Research. 29:1994;13-26.
51. Bahr R, Tjornhom M. Prevalence of doping in sports: doping control in Norway, 1977-1995. Clinical Journal of Sports Medicine. 8:1998;32-37.
52. Mottram D R. Banned drugs in sport: does the International Olympic Committee (IOC) list need updating? Sports Medicine. 27:1999;1-10.
53. Hoppeler H H, Matthias M F, Melia P S. Doping and prevention of doping: international cooperation. Clinical Journal of Sports Medicine. 5:1995;79-81.
54. Mottram D R, Reilly T, Chester N. Doping in sport: the extent of the problem. Reilly T, Orme M. Esteve Foundation Symposium. The Clinical Pharmacology of Sport and Exercise. 7:1997;3-12 Excerpta Medica, Amsterdam.
55. Laure P. Epidemiological approach of doping in sport. Journal of Sports Medicine and Physical Fitness. 37:1997;218-224.
56. Yesalis C E, Wright J E, Lombardo J A. Anabolic-androgenic steroids: a synthesis of existing data and recommendations for future research. Clinical Sports Medicine. 1:1989;109-134.
57. Honour J W. Steroid abuse in female athletes. Current Opinion in Obstetrics and Gynecology. 9:1997;181-186.
58. Nocelli L, Kamber M, Francois Y. Discordant public perceptions of doping in elite versus recreational sport in Switzerland. Clinical Journal of Sports Medicine. 8:1998;195-200.